Zolai Pharmaceutical (300181.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 495 million, down 3.00% year on year.

Zhitong Finance APP News, Zuoli Pharmaceutical (300181.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 2.51 billion yuan, a year-on-year increase of 10.10%. Net profit attributable to shareholders of the listed company was 495 million yuan, a year-on-year decrease of 3.00%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 496 million yuan, a year-on-year decrease of 2.42%.